Immunohistochemical study of carbohydrate antigen expression in gastric carcinoma (original) (raw)

• Yang HJ, Hakomori S: A sphingolipid having a novel type of ceramide and lacto-N-pentaose III. J Biol Chem 1971;246: 1192–1200.
  PubMed CAS Google Scholar
• McKibbin JM, Spenson WJ: Lewis blood group fucolipids and their isomers from human and canine intestine. Biol Chem 1982;257:755–760
  CAS Google Scholar
• Hakomori S, Kannagi R: Glycosphingolipids as tumor associated and differentiation markers. J Natl Cancer Inst 1983;71:232–251
  Google Scholar
• Hakomori S: Blood group glycolipid antigens. Am J Clin pathol 1984;82:635–648
  PubMed CAS Google Scholar
• Kannagi R, Nudelman E, Levery SB, et al:A series of human erythrocyte glycosphingolipids reacting to the monoclonal antibody directed to a developmentary regulated antigen, SSEA-1: J Biol chem 1982;257:14865–14874
  PubMed CAS Google Scholar
• Hakomori S, Nudelman E, Levery SB, et al:Novel fucolipids accumulating in human adenocarcinoma I. Glycolipids with di- or tri-fucosylated type 2 chain: J Biol Chem 1984;259:4672–4680
  PubMed CAS Google Scholar
• Fukushi Y, Hakomori S, Shepard T: Localization and alteration of mono-, di-, and trifucosyl α 1-3 type 2 chain structures during human embryogenesis and in human cancer. J Exp Med 1984;159:506–520
  Article Google Scholar
• Abe K, McKibbin JM, Hakomori S; The monoclonal antibody directed to difucosylated type 2 chain (Fuc α 1–2 Gal β 1–4 [Fuc α 1–3] GlcNAc; Y determinant). J Biol Chem 1983;258:11793–11797
  PubMed CAS Google Scholar
• Abe K, Hakomori S, Ohshiba S: differential expression of Difucosyl type 2 chain (Ley) defined by monoclonal antibody AH6 in different locations of colonic epithelia, various histological types of colonic polyps and adenocarcinomas, Cancer Res 1986;46:2639–2644
  PubMed CAS Google Scholar
• Brown A, Ellis IO, Embleton MJ, et al: Immunohistochemical localization of Y hapten and the structurally related H type-2 blood group antigen an large bowel tumours and normal adult tissues. Int J Cancer 1984;33:727–736
  Article PubMed CAS Google Scholar
• Fukushi Y, Kannagi F, Hakomori S, et al: Localization and distribution of difucoganglioside (VI3NeuAcV3III3Fuc2nLc6) in normal and tumor tissues defined by its monoclonal antibody FH6. Cancer Res. 1985;45:3711–3717
  PubMed CAS Google Scholar
• Chia D, Terasaki PI, Suyama N, et al: Use of monoclonal antibodies to sialylated Lewsx and sialylated Lewisa for serological test of cancer. Cancer Res 1985;45:435–437
  PubMed CAS Google Scholar
• Fukushi Y, Hakomori S, Nudelman E, et al: Novel fucolipids accumulating in human adenocarcinoma II. Selective isolation of hybridoma antibodies that differentially recognize mono-, di-, and trifucosylated type 2 chain, J Biol Chem 1984;259:4681–4685
  PubMed CAS Google Scholar
• Fukushi Y, Nodulman E, Levery SB, et al: Novel fucolipids accumulation in human adenocarcinoma III, A hybridoma antibody (FH6) defining a human cancer-associated difucoganglioside (VI3NeuAcV3III3Fuc2nLc6). J Biol Chem 1983;259:10511–10516
  Google Scholar
• Nakamura K, Sugano H, Takagi K, et al: Histopathololgical study on early carcinoma of the stomach: some considerations on the ulcer-cancer by analyses of 144 foci of the superficial spreading carcinomas. GANN 1967;58:377–387
  PubMed CAS Google Scholar
• Kaizu T, Levery SB, Nudelman E, et al: Novel fucolipids of human adenocarcinoma VI. Monoclonal antibody specific for trifucosyl Ley (III3FucV3VI2FucnLc6) which does not crossreact with Ley antigen, and a possible conformational epitope structure. J Biol Chem 1986;261:11254–11258
  PubMed CAS Google Scholar
• Kim YS, Itzkowitz SH, Yuan M, et al:Lex and Ley antigen expression in human pancreatic cancer. Cancer Res 1988;48:475–482
  PubMed CAS Google Scholar
• Fukushi Y, Orisaka S, Shepard T, et al: Change of Lex and Ley hapten and their sialylated antigens during development of human kidney and kidney tumors. J Urol 1986;135:1048–1056
  PubMed CAS Google Scholar
• Kannagi R, Miyake M, Zenita K, et al: Cancer associated carbohydrate antigens: Modified blood group substances and onco-developmental antigen on tumor cells. In cellular and molecular mechanisms of tumor immunity. In: Hamaoka T, Hashimoto Y, ed. Gann monogragh on cancer research. No. 34. Japan Scientific societies Press, Tokyo. 1988;15–28
  Google Scholar
• Fukushima K, Hirota M, Terasaki PI, et al: Characterization of sialosylated Lewisx as a new tumor associated antigen. Cancer Res 1984;44:5279–5285
  PubMed CAS Google Scholar
• Kannagi R, Fukushi Y, Tachikawa T, et al:Quantitative and qualitative characterization of human cancer-associated serum glycoprotein antigens expressing fucosyl or sialyl type 2 chain polylactosamine. Cancer Res 1986; 46:2619–2626
  PubMed CAS Google Scholar
• Morson BC: Precancerous lesions of upper gastrointestinal tract. JAMA 1962; 179:311–315
  PubMed CAS Google Scholar
• Ming S, Goldman H, Freiman DG: Intestinal mataplasia and histogenesis of carcinoma in human stomach. Cancer 1967; 20:1418–1429
  Article PubMed CAS Google Scholar